Radiolabeled antibody fragments
Patent
·
OSTI ID:5468404
This patent describes an antibody conjugate of the formula: wherein Ab is the residue of a Fab fragment of a monoclonal antibody. The antibody being one which retains antigen-binding activity following enzymatic removal for the F/sub c/ fragment and reductive cleavage of the disulfide bond joining the heavy chains; -S- is the residue of the free sulfhydryl group of the Fab' fragment; R is a divalent organic linker; and R' is a nontoxic, weakly acidic chelating group capable of forming a chelate with a radionuclide metal ion that is thermodynamically stable under physiological conditions and has a higher stability constant than a chelate of the radionuclide with transferrin in vivo.
- Assignee:
- Mallinckrodt, Inc., St. Louis, MO
- Patent Number(s):
- US 4837003
- Application Number:
- PPN: US 6650127A; TRN: 89-031320
- OSTI ID:
- 5468404
- Resource Relation:
- Patent File Date: 13 Sep 1984
- Country of Publication:
- United States
- Language:
- English
Similar Records
New Insights into the Functional Behavior of Antibodies as Revealed by Binding Studies on an Anti-Uranium Monoclonal Antibody
In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: Enhanced divalent hapten affinity for cell-bound antibody conjugate
Higher cytotoxicity of divalent antibody-toxins than monovalent antibody-toxins
Conference
·
Wed Mar 17 00:00:00 EST 2004
·
OSTI ID:5468404
+1 more
In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: Enhanced divalent hapten affinity for cell-bound antibody conjugate
Journal Article
·
Tue Aug 01 00:00:00 EDT 1989
· Journal of Nuclear Medicine; (USA)
·
OSTI ID:5468404
+2 more
Higher cytotoxicity of divalent antibody-toxins than monovalent antibody-toxins
Journal Article
·
Fri Apr 24 00:00:00 EDT 2009
· Biochemical and Biophysical Research Communications
·
OSTI ID:5468404
+1 more
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
MONOCLONAL ANTIBODIES
LABELLING
BINDING ENERGY
CHELATES
CHEMICAL COMPOSITION
IN VIVO
LABELLED COMPOUNDS
NUCLEAR MEDICINE
RADIOIMMUNOTHERAPY
RADIOISOTOPES
RADIOPHARMACEUTICALS
SULFIDES
ANTIBODIES
CHALCOGENIDES
COMPLEXES
DRUGS
ENERGY
IMMUNOLOGY
IMMUNOTHERAPY
ISOTOPES
MEDICINE
RADIOIMMUNOLOGY
RADIOLOGY
RADIOTHERAPY
SULFUR COMPOUNDS
THERAPY
550604* - Medicine- Unsealed Radionuclides in Therapy- (1980-)
MONOCLONAL ANTIBODIES
LABELLING
BINDING ENERGY
CHELATES
CHEMICAL COMPOSITION
IN VIVO
LABELLED COMPOUNDS
NUCLEAR MEDICINE
RADIOIMMUNOTHERAPY
RADIOISOTOPES
RADIOPHARMACEUTICALS
SULFIDES
ANTIBODIES
CHALCOGENIDES
COMPLEXES
DRUGS
ENERGY
IMMUNOLOGY
IMMUNOTHERAPY
ISOTOPES
MEDICINE
RADIOIMMUNOLOGY
RADIOLOGY
RADIOTHERAPY
SULFUR COMPOUNDS
THERAPY
550604* - Medicine- Unsealed Radionuclides in Therapy- (1980-)